ArticleJournal of cellular and molecular medicine2020

Neobavaisoflavone inhibits osteoclastogenesis through blocking RANKL signalling-mediated TRAF6 and c-Src recruitment and NF-κB, MAPK and Akt pathways.

Huiwen Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.